These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2323828)

  • 21. Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18-45.
    McCarty JM; Lock MD; Hunt KM; Simon JK; Gurwith M
    Vaccine; 2018 Feb; 36(6):833-840. PubMed ID: 29317118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of Vibrio cholerae O1 fimbriae in animal and human cholera.
    Ehara M; Ichinose Y; Iwami M; Utsunomiya A; Shimodori S; Kangethe SK; Neves BC; Supawat K; Nakamura S
    Microbiol Immunol; 1993; 37(9):679-88. PubMed ID: 7505875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Persistence in the mouse gut as an important factor in oral immunogenicity of strains of V. cholerae.
    Bloom L; Rowley D
    Aust J Exp Biol Med Sci; 1979 Jun; 57(3):325-33. PubMed ID: 533484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. recA mutations reduce adherence and colonization by classical and El Tor strains of Vibrio cholerae.
    Kumar KK; Srivastava R; Sinha VB; Michalski J; Kaper JB; Srivastava BS
    Microbiology (Reading); 1994 May; 140 ( Pt 5)():1217-22. PubMed ID: 8025688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.
    Taylor DN; Tacket CO; Losonsky G; Castro O; Gutierrez J; Meza R; Nataro JP; Kaper JB; Wasserman SS; Edelman R; Levine MM; Cryz SJ
    Infect Immun; 1997 Sep; 65(9):3852-6. PubMed ID: 9284163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles.
    Yeh MK; Liu YT; Chen JL; Chiang CH
    J Control Release; 2002 Aug; 82(2-3):237-47. PubMed ID: 12175740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.
    Lagos R; Avendaño A; Prado V; Horwitz I; Wasserman S; Losonsky G; Cryz S; Kaper JB; Levine MM
    Infect Immun; 1995 Feb; 63(2):707-9. PubMed ID: 7822046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preliminary assessment of the safety and immunogenicity of live oral cholera vaccine strain CVD 103-HgR in healthy Thai adults.
    Migasena S; Pitisuttitham P; Prayurahong B; Suntharasamai P; Supanaranond W; Desakorn V; Vongsthongsri U; Tall B; Ketley J; Losonsky G
    Infect Immun; 1989 Nov; 57(11):3261-4. PubMed ID: 2807523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101.
    Yu F; Qi G; Liu Y; Gao S; Kan B
    Mol Biotechnol; 2005 Mar; 29(3):191-6. PubMed ID: 15767696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.
    Levine MM; Kaper JB; Herrington D; Ketley J; Losonsky G; Tacket CO; Tall B; Cryz S
    Lancet; 1988 Aug; 2(8609):467-70. PubMed ID: 2900401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection and immunity to Vibrio cholerae, Salmonella typhimurium and Escherichia coli in a rabbit model.
    Guinée PA; Jansen WH; Rijpkema SG
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov; 270(1-2):260-9. PubMed ID: 2464884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic and vaccine significance of toxin-coregulated pili of Vibrio cholerae E1 Tor.
    Attridge SR; Voss E; Manning PA
    J Biotechnol; 1999 Aug; 73(2-3):109-17. PubMed ID: 10486921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
    Kaper JB; Levine MM
    Res Microbiol; 1990; 141(7-8):901-6. PubMed ID: 2101480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
    Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
    Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular cloning and expression in Escherichia coli K-12 of the O antigens of the Inaba and Ogawa serotypes of the Vibrio cholerae O1 lipopolysaccharides and their potential for vaccine development.
    Manning PA; Heuzenroeder MW; Yeadon J; Leavesley DI; Reeves PR; Rowley D
    Infect Immun; 1986 Aug; 53(2):272-7. PubMed ID: 2426198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunisation against cholera with a Ty21a-cholera hybrid.
    La Brooy JT; Forrest B; Bartholomeusz C
    Ann Sclavo Collana Monogr; 1986; 3(1-2):143-7. PubMed ID: 3426872
    [No Abstract]   [Full Text] [Related]  

  • 39. Safe, live Vibrio cholerae vaccines?
    Taylor R; Shaw C; Peterson K; Spears P; Mekalanos J
    Vaccine; 1988 Apr; 6(2):151-4. PubMed ID: 2898843
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and validation of a detection system for wild-type Vibrio cholerae in genetically modified cholera vaccine.
    Studer E; Candrian U
    Biologicals; 2000 Sep; 28(3):149-54. PubMed ID: 10964441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.